BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20251011
DTSTAMP:20260526T181428
CREATED:20250221T135021Z
LAST-MODIFIED:20251009T092733Z
UID:181026-1758499200-1760140799@www.bordeaux-neurocampus.fr
SUMMARY:Cajal lectures: "Cancer and Neuroscience"
DESCRIPTION:Venue : CARF \nOrganized by the Bordeaux School of Neuroscience. \nLectures are open to everyone. \n\n\n\nProgramme\n\n\n\n\nMonday 22 September – 11:00am\nAnna Golebiewska (Luxembourg Institute of Health\, Luxembourg)\nHeterogeneity and plasticity of the brain tumor ecosystem: What can we learn from advanced patient-derived models? \nTuesday 23 September – 9:00am\nSimona Parrinello (University College London\, UK)\nInjury programmes shape gliomagenesis. \nTuesday 23 September – 11:00am\nHenrik Heiland (Dep. of Neurosurgery\, University Clinic Erlangen\, Germany)\nTBA\n \nThursday 25 September – 9:00am\n Hélène Castel (Cancer and Brain Genomics\, Inserm\, University of Rouen\, France)\nNeurosciences in Oncology: When Cancer Thinks Out of the Box. \nThursday 25 September – 11:00am \nThomas Daubon (CNRS\, University of Bordeaux\, France)\nLactate Shuttle between Glioblastoma Cells and Neurons: a Cancer Neuroscience Case. \nMonday 29 September – 9:00am\nFranck Winkler (University of Heidelberg\, Germany)\nCancer Neuroscience of Brain Tumors. \nMonday 29 September – 11:00am \nVidhya M. Ravi (Medical Centre University Clinic of Freiburg\, Germany)\nTumor–Host Interdependence: Decoding the Microenvironmental Dialogue. \nThursday 2 October – 9:00am \nHrvoye Miletic (University of Bergen\, Norway)\nCell communication and mitochondria transfer in brain tumors. \nThursday 2 October – 11:00am\nManuel Valiente (Spanish National Cancer Research Centre\, Spain)\nThe Evolving Landscape of Brain Metastases. \nFriday 3 October – 9:00am\nLeila Akkari (Netherlands Cancer Institute\, The Netherlands)\nMacrophages: Jack of all Trades in the Brain Ecosystem? \nMonday 6 October – 9:00am\nVarun Venkataramani (German Cancer Research Center\, Germany)\nTBA \nOctober 6 – 11:00am\nAurélie Tchoghandjian (Institute of Neurophysiopathology\, Marseille\, France)\nGlioblastoma stemness and immunosuppression: breaking the lethal cycle. \nOctober 9 – 9:00am\nAntonio Pagano Zottola (Bordeaux Institute of Oncology\, University of Bordeaux\, France)\nMitoDREADD: a new mitochondria-specific chemogenetic tool. \n\n\n\nCourse Directors \n\nAnna Golebiewska – Luxembourg Institute of Health\, Luxembourg\nAntonio C. Pagano Zottola – Bordeaux Institute of Oncology – Inserm\, France\nVarun Venkataramani – Universität Heidelberg\, Germany\n\n\nMore details about the course \n
URL:https://www.bordeaux-neurocampus.fr/en/event/cajal-lectures-cancer-and-neuroscience/
CATEGORIES:Cajal Lectures,For scientists
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251006
DTEND;VALUE=DATE:20251010
DTSTAMP:20260526T181428
CREATED:20241016T084847Z
LAST-MODIFIED:20251009T092654Z
UID:177041-1759708800-1760054399@www.bordeaux-neurocampus.fr
SUMMARY:FINS 2025
DESCRIPTION:Venue: Centre Broca \n\nCo-organised by the Interdisciplinary Institute for Neuroscience (IINS) and the Bordeaux and Quebec Imaging Centers\, the Frontiers In Neurophotonics Symposium (FINS) 2025 will be the 7th in a biennial series of conferences dedicated to the new frontiers of microscopy and neuroscience. FINS brings together world experts to discuss and debate new developments in the field and how they can be used to study brain function. The world’s leading experts in the field of neuroimaging (including Nobel Prize winners) attend this biennial event.\nPrevious editions have alternated between Bordeaux (2009\, 2013\, 2017) and Quebec City (2011\, 2015\, 2022)\, attracting around 150 participants from all over the world. \nScientific committee:\n \n\nAnna Brachet (Bordeaux)\nDaniel Choquet (Bordeaux)\nLaurent Cognet (Bordeaux)\nPaul De Koninck (Laval)\nYves De Koninck (Laval)\nMathieu Ducros (Bordeaux)\nFlavie Lavoie-Cardinal (Laval)\nMarie-Eve Paquet (Laval)\nJean-Baptiste Sibarita (Bordeaux)\n\nAll details on: https://frontiersneurophotonics.org/ \nDonwload the Abstract Book FINS 2025 \n
URL:https://www.bordeaux-neurocampus.fr/en/event/fins-2025/
CATEGORIES:For scientists,IINS,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251006
DTEND;VALUE=DATE:20251011
DTSTAMP:20260526T181428
CREATED:20250425T164326Z
LAST-MODIFIED:20251001T092950Z
UID:183450-1759708800-1760140799@www.bordeaux-neurocampus.fr
SUMMARY:Neuroscience Alliance Workshop
DESCRIPTION:Venue: Bordeaux \n\nEmergent Properties of the Connected Brain \nMore details \n  \n
URL:https://www.bordeaux-neurocampus.fr/en/event/neuroscience-alliance-workshop/
CATEGORIES:For scientists,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251009T150000
DTEND;TZID=Europe/Paris:20251009T150000
DTSTAMP:20260526T181428
CREATED:20250922T182833Z
LAST-MODIFIED:20250923T063749Z
UID:188155-1760022000-1760022000@www.bordeaux-neurocampus.fr
SUMMARY:Soutenance d'HDR - Camille Jeunet
DESCRIPTION:Lieu : BBS \nEt en visio : https://u-bordeaux-fr.zoom.us/j/7838516638?omn=87398689414 \n\nCamille Jeunet\nINCIA\nEquipe Mococo \nTitle\nEEG-based neurofeedback training procedures to improve or restore motor abilities: A user-centred approach \nAbstract\nOver the past decades\, brain-computer interfaces (BCIs) and neurofeedback (NF) technologies have held the promise of radically transforming the way we assess\, restore\, and enhance human function. Initially conceived as tools to facilitate communication for locked-in patients or to control devices through mere brain activity\, they are now increasingly investigated as cognitive training tools in clinical and high-performance domains. Yet despite this wealth of research and promise\, their real-world implementation remains limited\, and their societal impact marginal. This discrepancy calls for approaches that consider both usability\, acceptability\, and efficiency\, especially in domains where user engagement is paramount. My research addresses this challenge by aiming to foster the realworld adoption and impact of NF procedures targeting motor function. I have developed a user-centred\, theory-informed approach\, grounded at the intersection of cognitive neuroscience\, neuroengineering\, ergonomics\, and clinical sciences. Three main axes structure my research. The first investigates NF as a tool to explore neural and cognitive mechanisms\, particularly in Parkinson’s disease (PD)\, where β-band activity is pathologically elevated. Through several studies\, we demonstrated that cortical β oscillations are better understood as markers of contextual adaptability rather than pure movement vigour. We further showed that closed-loop NF enhances patients’ ability to modulate β activity\, with performance influenced by the transparency of the feedback and the sense of agency it evokes. In low-agency contexts\, increased fronto-central θ activity emerged\, indicating compensatory cognitive control. These findings help refine both theoretical understanding and protocol design for motor symptom alleviation in PD. The second axis focuses on NF in post-stroke rehabilitation for which clinical implementation remains marginal despite accumulative evidence of efficacy. Here\, we chose to prioritise user acceptability\, hypothesising that improving perceived relevance and usability will enhance both engagement and motor outcomes. Our work identified a lack of theoretical models and validated tools to measure NF acceptability. We addressed this gap by developing and validating a theoretical model and a dedicated questionnaire\, made freely available online. Results showed that while perceived scientific relevance and ease of use are key for the general population\, individual traits —such as anxiety\, self-efficacy\, and autonomy— strongly influence stroke survivors. This led to the development of a personalisation methodology\, implemented in a plug-and-play NF platform currently tested in a multicentre clinical trial. Additional work includes a digital exhibition to counter widespread misconceptions and a new line of investigation focused on healthcare professionals\, whose engagement is critical for clinical integration. The third axis explores NF as a performance optimisation tool in sport. Although mental preparation is central in elite contexts\, it is often under-instrumented and dependent on subjective evaluation. A systematic review revealed limited NF integration in athletic routines\, partly due to misaligned training goals\, neural targets\, and feedback strategies. We proposed methodological recommendations to address these gaps. Moreover\, sport introduces a unique challenge: the role of expertise. We found that sensorimotor rhythm modulation differs by expertise level\, with stronger ERD in intermediate-level athletes\, suggesting a potential inverted U-shaped trajectory leading to neural efficiency in experts. A second study showed that novices benefit from sustained explanatory feedback\, while experts rely more on precise evaluative cues. These insights support more tailored NF strategies in high-performance contexts. Taken together\, these projects reflect a strong translational commitment. They have yielded academic publications\, public engagement activities\, freely accessible tools\, clinical software\, a patent\, and the creation of a start-up. However\, they also underscore a structural limitation of the field: despite over 50 years of research\, BCI/NF technologies have yet to achieve widespread clinical or societal impact. To investigate why\, we initiated an analysis of the global research and innovation landscape\, aiming to assess whether current efforts are aligned with field-wide ambitions—and whether a strategic shift is needed. Looking forward\, my short-term goal is to complete ongoing work across the BETAPARK\, ABCIS\, and neurathletics projects. Long-term\, I aim to help define the conditions under which NF/BCI technologies can become scalable\, effective\, and ethically sound interventions. This requires not only reliable tools and personalised strategies but a broader shift toward Responsible\, Collaborative\, Open\, and Participatory (R-COP) science. I view this dual strategy —academic transformation and real-world experimentation— as the key to unlocking NF’s true societal potential.\n
URL:https://www.bordeaux-neurocampus.fr/en/event/soutenance-dhdr-camille-jeunet/
CATEGORIES:HDR,home-event
END:VEVENT
END:VCALENDAR